In March 2025, the company announced new programs for any direct-to-consumer supplying of its Wegovy weight loss drug. The company recognized a whole new pharmacy, referred to as NovoCare, which might cost shoppers $499 per month for entry to the drug, below half the cost of the drug by way of other pharmaceutical distribution networks.[53]Wegovy®